prader willi syndrome and glp 1 Weight Loss of Over 100 lbs in a Patient of Prader-Willi Treated With Glucagon-Like Peptide-1 (GLP-1) Agonists No Role for Ghrelin, GLP-1

These findings suggest that ACs antivirulence properties could be complementary to the existing antibiotic therapies, addressing the rising challenge of antibiotic-resistant lung infections

The appeal of novel weight-loss compounds is understandable, but the risks of self-administering unlicensed injectables without medical oversight are substantial and should not be underestimated

Alzheimer patients show a straight line relationship between alpha estrogen receptors and cognitive function

7) Addiction: Exploring New Avenues for Treatment Emerging research suggests a potential role for GLP-1 medications in mitigating cravings and dependence associated with addictive substances